J P Devogelaer
Overview
Explore the profile of J P Devogelaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
2052
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rizzoli R, Adachi J, Cooper C, Dere W, Devogelaer J, Diez-Perez A, et al.
Calcif Tissue Int
. 2012 Aug;
91(4):225-43.
PMID: 22878667
This review summarizes the available evidence-based data that form the basis for therapeutic intervention and covers the current status of glucocorticoid-induced osteoporosis (GIOP) management, regulatory requirements, and risk-assessment options. Glucocorticoids...
2.
Reginster J, Kaufman J, Goemaere S, Devogelaer J, Benhamou C, Felsenberg D, et al.
Osteoporos Int
. 2011 Nov;
23(3):1115-22.
PMID: 22124575
Unlabelled: In an open-label extension study, BMD increased continuously with strontium ranelate over 10 years in osteoporotic women (P < 0.01). Vertebral and nonvertebral fracture incidence was lower between 5...
3.
Bergmann P, Body J, Boonen S, Boutsen Y, Devogelaer J, Goemaere S, et al.
J Osteoporos
. 2011 Jan;
2011:786752.
PMID: 21209784
Mechanical loading is a major regulator of bone mass and geometry. The osteocytes network is considered the main sensor of loads, through the shear stress generated by strain induced fluid...
4.
Neuprez A, Johansson H, Kanis J, McCloskey E, Oden A, Bruyere O, et al.
Rev Med Liege
. 2010 Feb;
64(12):612-9.
PMID: 20143744
The objective of this study was to evaluate a Belgian version of the WHO fracture risk assessment (FRAX) tool to compute 10-year probabilities of osteoporotic fracture in men and women....
5.
Cornelis M, Mahy P, Devogelaer J, De Clerck H, Nyssen-Behets C
Orthod Craniofac Res
. 2010 Jan;
13(1):21-7.
PMID: 20078791
Objectives: To evaluate whether orthodontic loading has an effect on miniplate stability and bone mineral density (BMD) around the screws supporting those miniplates. Setting And Sample Population: Two miniplates were...
6.
Reginster J, Bruyere O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, et al.
Bone
. 2009 Aug;
45(6):1059-64.
PMID: 19679207
Objectives: Strontium ranelate 2 g/day has proven efficacy against vertebral and nonvertebral fracture over 5 years in postmenopausal osteoporosis, though many women require longer-term treatment. This article describes the efficacy,...
7.
Mousny M, Omelon S, Wise L, Everett E, Dumitriu M, Holmyard D, et al.
Bone
. 2008 Aug;
43(6):1067-74.
PMID: 18755305
Introduction: A variation in bone response to fluoride (F(-)) exposure has been attributed to genetic factors. Increasing fluoride doses (0 ppm, 25 ppm, 50 ppm, 100 ppm) for three inbred...
8.
Body J, Bergmann P, Boonen S, Boutsen Y, Devogelaer J, Goemaere S, et al.
Osteoporos Int
. 2007 Aug;
18(11):1439-50.
PMID: 17690930
Cancer treatment-induced bone loss (CTIBL) is one of the most important side effects of adjuvant antineoplastic treatment in hormone-dependent neoplasms. Chemotherapy, GnRH analogs and tamoxifen can induce marked bone loss...
9.
Devogelaer J, Brown J, Burckhardt P, Meunier P, Goemaere S, Lippuner K, et al.
Osteoporos Int
. 2007 May;
18(9):1211-8.
PMID: 17516022
Unlabelled: In a 5-year study involving 119 postmenopausal women, zoledronic acid 4 mg given once-yearly for 2, 3 or 5 years was well tolerated with no evidence of excessive bone...
10.
Alexopoulou O, Jamart J, Devogelaer J, Brichard S, DE NAYER P, Buysschaert M
Diabetes Metab
. 2006 Nov;
32(5 Pt 1):453-8.
PMID: 17110900
Aims: To assess the prevalence and severity of bone disease in type 1 diabetic patients and to determine serum markers of bone remodeling as well as their relationship with bone...